Discover how Signant Health's new AI-driven tool, Forecasting & Planning Assist™, revolutionizes clinical supply management with enhanced data insights.

Signant Health and Lothar Medical announced a collaboration to develop ALDS PRO, a cutting-edge respiratory assessment tool for clinical trials, enhancing treatment evaluation.

Signant Health has introduced a newly redesigned patient interface for their TrialMax eCOA solution, aimed at enhancing usability and accessibility in clinical trials.

Signant Health has achieved a significant milestone with over 9,000 translations in its eCOA library, enhancing the launch speed of global studies. This development streamlines the clinical trial process considerably.

Signant Health will engage the CNS community at ASCP 2026, showcasing advancements post-acquisition of Ametris for improved clinical trials.

Signant Health's acquisition of Ametris aims to create a comprehensive platform for clinical trials that integrates patient-reported outcomes and wearable health data.

Signant Health has announced a definitive agreement to acquire Ametris, a global leader in digital health solutions, enhancing its capabilities.

Signant Health is enhancing its capabilities in metabolic disease and diabetes research with the appointment of Dr. Graham C. Ellis as Clinical VP.

Signant Health has appointed John Harrison as Clinical Vice President to enhance cognitive assessment in Alzheimer’s and CNS trials.

Signant Health has announced the appointment of Krishna Maridi as CFO, bringing over 25 years of finance experience, vital for its growth.